Cargando…
Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol
PURPOSE: To examine predictors of understanding preemptive CYP2D6 pharmacogenomic test results and to identify key features required to improve future educational efforts of preemptive pharmacogenomic testing. METHODS: 1010 participants were surveyed after receiving preemptive CYP2D6 pharmacogenomic...
Autores principales: | Olson, Janet E., Rohrer Vitek, Carolyn R., Bell, Elizabeth J., McGree, Michaela E., Jacobson, Debra J., St. Sauver, Jennifer L., Caraballo, Pedro J., Griffin, Joan M., Roger, Veronique L., Bielinski, Suzette J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498279/ https://www.ncbi.nlm.nih.gov/pubmed/28055020 http://dx.doi.org/10.1038/gim.2016.192 |
Ejemplares similares
-
Are patients willing to incur out of pocket costs for pharmacogenomic testing?
por: Bielinski, Suzette J., et al.
Publicado: (2016) -
Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort
por: Swanson, Kristi M., et al.
Publicado: (2020) -
An assessment of patient perspectives on pharmacogenomics educational materials
por: Asiedu, Gladys B, et al.
Publicado: (2020) -
Cohort study examining associations between ceramide levels and risk of multimorbidity among persons participating in the Mayo Clinic Biobank
por: St Sauver, Jennifer L, et al.
Publicado: (2023) -
Pharmacogenomics: The Right Drug to the Right Person
por: T P, Aneesh, et al.
Publicado: (2009)